Company profile: Moberg
1.1 - Company Overview
Company description
- Provider of medical devices and neurodiagnostic solutions, including RetCam Envision pediatric ophthalmic imaging, Otoscan 3D ear scanning for auditory assessments, Natus NeuroWorks EEG analysis software, UltraPro S100 EMG/NCS/EP neurodiagnostic systems, and dedicated service and support for efficient workflows and optimal patient outcomes.
Products and services
- Natus NeuroWorks EEG Software: Clinical-grade EEG analysis software platform supporting neurodiagnostic evaluations with comprehensive tools for detailed EEG analysis tasks
- Otoscan: Clinical-grade 3D ear scanning system producing detailed images for auditory assessments, designed to deliver precise ear scans for hearing-related evaluations
- RetCam Envision: Pediatric-optimized ophthalmic imaging system delivering high-quality images and an efficient workflow for pediatric use in eye imaging
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Moberg
Impulse Monitoring
HQ: United States
Website
- Description: Provider of intraoperative neurophysiologic monitoring solutions to hospitals and other healthcare facilities, offering insight into the nervous system during spinal, nerve, and brain-related surgeries. Solutions include IONM delivering real-time data and alerts to help reduce surgical risk, plus EEG, ECoG, EMG, and SSEP for diagnosis and intraoperative monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Impulse Monitoring company profile →
Vaxxinity
HQ: United States
Website
- Description: Provider of synthetic peptide vaccine technologies and Active Immunotherapy Medicines (AIMs) that stimulate antibody production to address chronic and infectious diseases, including UB-311 for mild Alzheimer’s (targets amyloid beta), UB-312 for Parkinson’s (targets alpha-synuclein), VXX-401 anti-PCSK9 to reduce LDL-C for heart disease, and UB-612, a multitope protein-peptide vaccine against SARS-CoV-2 variants like Omicron.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vaxxinity company profile →
Zynex Medical
HQ: United States
Website
- Description: Provider of medical devices of its own design, engineered, manufactured, marketed, and sold by Zynex through three subsidiaries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zynex Medical company profile →
Arvelle Therapeutics
HQ: Switzerland
Website
- Description: Provider of innovative biopharmaceutical solutions for patients suffering from central nervous system (CNS) disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arvelle Therapeutics company profile →
Burl Concepts
HQ: United States
Website
- Description: Provider of a portable, battery-powered ultrasound device for non-invasive, transcranial brain perfusion assessment and stroke diagnosis. The SONAS system uses microbubble contrast agents to detect cerebral blood perfusion differences.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Burl Concepts company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Moberg
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Moberg
2.2 - Growth funds investing in similar companies to Moberg
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Moberg
4.2 - Public trading comparable groups for Moberg
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →